bioAffinity Technologies
Business Services · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3300 Nacogdoches Rd Ste 216, San Antonio...Phone Number
(210) 698-5334Website
www.bioaffinitytech.comRevenue
$5.6 MillionStock Symbol
BIAFIndustry
About bioAffinity Technologies
bioAffinity Technologies Org Chart
Is bioAffinity Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on bioAffinity Technologies recently announced quarterly report
Click to see if bioAffinity Technologies had a recent Job posting/layoffs
Funding: Get notified immidiatlly once bioAffinity Technologies has new funding data
bioAffinity Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if bioAffinity Technologies is spiking on competitors!
Product Launch: Get notified when bioAffinity Technologies launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at bioAffinity Technologies
Check if bioAffinity Technologies has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to bioAffinity Technologies
Compare insights from companies similar to bioAffinity Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
bioAffinity Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
bioAffinity Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about bioAffinity Technologies.
bioAffinity Technologies financials insights
Gather financial insights about bioAffinity Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$4M
Debt
$150K
Debt
$5M
Debt
$212K
Share Placement
$2.5M
Share Placement
$1.4M
bioAffinity Technologies Tech Stack
A closer look at the technologies used by bioAffinity Technologies
Most Recent Scoops
bioAffinity Technologies News & Media
bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right?
bioAffinity Technologies jumped 47.95% on September 2, one day after announcing that it was advancing the potential use of CyPath Lung for post-treatment surveillance of lung-cancer patients. The move followed a 1-for-15 reverse split that became effective for trading on August 24, a combination that can produce dramatic percentage swings in a thinly traded stock. […]WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
JERSEY CITY, N.J., Aug. 14, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early...WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering
JERSEY CITY, N.J., June 18, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive,...WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering
JERSEY CITY, N.J., June 17, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive,...



